BBVA
TRIL

Banco Bilbao Vizcaya Argentaria’s Trillium Therapeutics Inc. TRIL Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio TRIL Stock Details TRIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-25,984
Closed -$210K – 799
2020
Q2 		$210K Buy
+25,984
New +$161K 0.01% 702

Other funds holding TRIL

VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's TRIL Position: Q3 2020 in Review

Banco Bilbao Vizcaya Argentaria sold out of Trillium Therapeutics Inc. (TRIL) in Q3 2020, closing a stake of 25,984 shares — an estimated $210K sold.

Banco Bilbao Vizcaya Argentaria first reported a position in TRIL in Q2 2020 and held it in 1 quarter. The position peaked at $210K in Q2 2020. 114 funds tracked by Wall St. Rank hold TRIL as of Q3 2020.

  • Banco Bilbao Vizcaya Argentaria reported no remaining Trillium Therapeutics Inc. position as of Q3 2020 after selling out during the quarter.
  • Banco Bilbao Vizcaya Argentaria sold 25,984 Trillium Therapeutics Inc. shares in Q3 2020, an estimated $210K.
  • Banco Bilbao Vizcaya Argentaria first reported a position in Trillium Therapeutics Inc. in Q2 2020 and held it in 1 quarter.
  • Banco Bilbao Vizcaya Argentaria's Trillium Therapeutics Inc. position peaked at $210K in Q2 2020.
  • 114 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q3 2020.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q3 2020, filed 12 Nov 2020.